Metraipolis › archive › dc_a3728764de7e

ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy — Europe PMC PMID:41711765

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41711765
DOI
10.1590/0102-67202025000051e1920
License (as archived)
solo-consultazione
Archived
2026-11-05T18:04:32.727Z
SHA-256 of the archived text
17692c4479e6254b4f897f7112dcac2b176b7dc04d67fc536ea93c122d0a5822
Stable URL of this page
https://metraipolis.com/documento/dc_a3728764de7e

How to cite

ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy — Europe PMC PMID:41711765 — Europe PMC (en), https://europepmc.org/article/MED/41711765 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3728764de7e (Metraipolis archive dc_a3728764de7e, sha256 17692c4479e6254b4f897f7112dcac2b176b7dc04d67fc536ea93c122d0a5822)
BibTeX
@misc{dca3728764de7e,
  title = {ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy — Europe PMC PMID:41711765},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41711765},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3728764de7e; sha256 17692c4479e6254b4f897f7112dcac2b176b7dc04d67fc536ea93c122d0a5822},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41711765. Agents can read the archived copy with the MCP tool read_document.